U.S. Respiratory Syncytial Virus Vaccines Market to reach a market valuation of US$ 1.7 Bn by the end of 2032
April 19, 2022 11:30 ET
|
Persistence Market Research
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- According to recent industry analysis on the U.S. respiratory syncytial virus vaccines market by Persistence Market Research, a leading market research...